Asia-Pacific Asparaginase Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)
The APAC asparaginase market is expected to grow from US$ 132.43 million in 2022 to US$ 341.39 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028.
Increase in Pharmaceutical R&D Activities and Investment by Market Players
The pharmaceutical industry is developing at a significant rate, and developed countries are investing heavily in the development of novel treatments for various diseases. The government-supported research funding in the industry and a surge in R&D activities for developing asparaginase with high compatibility and reduced side effects are expected to contribute to the asparaginase market growth. In addition, market players are collaborating on the production of asparaginase, which is being used as an active pharmaceutical ingredient in the pharmaceutical industry. Governments of various countries and asparaginase producers are investing heavily in the R&D of asparaginase, which is further expected to contribute to the market growth in the coming years. Furthermore, the rising need for better stability in the pharmaceutical industry to ensure efficient storage and transportation of drugs has also increased the R&D activities in the industry. Thus, all the factors mentioned above are expected to drive the asparaginase market growth over the forecast period.
Market Overview
The APAC asparaginase market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. Further, China dominated the market in 2022. The growth of the market is primarily attributed to the growing pharmaceutical market, increasing developments by the market players, and favorable regulatory policies. The growing population of China and the rising prevalence of cancer are majorly driving the demand for cancer treatment drugs, such as asparaginase, in the country, making it a prime market in the region. As per the WHO report, in 2020, there were ~4,568,754 new cases of cancer and 3,002,899 deaths due to cancer in China. According to the Global Burden Disease (GBD) 2017 report, an estimated 141,317 new cases and 60,010 deaths of leukemia occurred in China, accounting for 27.3% of 518,485 new cases and 17.3% of 347,583 deaths worldwide, respectively. JINLAN Pharm-Drugs Technology Co., Ltd.; Jiwan Pharmaceutical Technology Co., Ltd; and Changzhou Qianhong are a few of the major Chinese market players that are producing and supplying asparaginase to many countries for the treatment of acute lymphoblastic leukemia (ALL) as part of a multi-agent chemotherapeutic regimen. Thus, a huge cancer patient population and developments in treatment for the disease by the market players are expected to propel the demand for asparaginase in the country.
APAC Asparaginase Market Revenue and Forecast to 2028 (US$ Million)
APAC Asparaginase Market Segmentation
The APAC asparaginase market is segmented based on type, application, end-use industry, and country.
Based on type, the APAC asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022. Based on application, the APAC asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the APAC asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held the larger market share in 2022. Based on country, the APAC asparaginase market has been categorized into China, Japan, India, Australia, South Korea, and rest of APAC. Our regional analysis states that China dominated the market in 2022. Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the APAC asparaginase market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Asparaginase Market – By Type
1.3.2 APAC Asparaginase Market – By Application
1.3.3 APAC Asparaginase Market – By End-Use Industry
1.3.4 APAC Asparaginase Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Asparaginase Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Asparaginase Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Leukemia and Increasing Usage Application
5.1.2 Significant Growth of Pharmaceutical and Food Industry
5.2 Market Restraints
5.2.1 Side Effects Associated With Use of Asparaginase
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.4 Future Trends
5.4.1 Increase in R&D Activities and Investment by Market Players
5.5 Impact Analysis
6. Asparaginase Market– APAC Analysis
6.1 APAC Asparaginase Market Revenue Forecasts and Analysis
7. APAC Asparaginase Market Analysis – By Type
7.1 Overview
7.2 By Type: APAC Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Escherichia Coli
7.2.1.1 Overview
7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Erwinia Chrysanthemi
7.2.2.1 Overview
7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
7.2.3 Pegylated
7.2.3.1 Overview
7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)
7.2.4 Others
7.2.4.1 Overview
7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. APAC Asparaginase Market Analysis – By Application
8.1 Overview
8.2 By Application: APAC Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Therapeutic
8.2.1.1 Overview
8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)
8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 Lymphoblastic Lymphoma (LBL)
8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.5 Others
8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Food Processing
8.2.2.1 Overview
8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)
8.2.3 Others
8.2.3.1 Overview
8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Asparaginase Market Analysis – By End-use Industry
9.1 By End-Use: APAC Market Revenue and Forecast Analysis (US$ Million)
9.1.1 Healthcare
9.1.1.1 Overview
9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)
9.1.2 Food Manufacturing
9.1.2.1 Overview
9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Asparaginase Market – Country Analysis
10.1 Overview
10.1.1 APAC: Asparaginase Market, by Country, 2021 & 2028 (%)
10.1.1.1 China Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.4 China: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.4.1 China Asparaginase Market, by Therapeutic Application – 2020 - 2028 (US$ Million)
10.1.1.1.5 China: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
10.1.1.2 Japan Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.4.1 Japan: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
10.1.1.3 India Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.4 India: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.4.1 India: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.3.5 India: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
10.1.1.4 Australia Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Australia: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.4 Australia: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.4.1 Australia: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.4.5 Australia: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
10.1.1.5 South Korea Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 South Korea: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.5.4 South Korea: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.4.1 South Korea: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.5.5 South Korea: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
10.1.1.6 Rest of APAC Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of APAC: Asparaginase Market, by Type, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of APAC: Asparaginase Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.4.1 Rest of APAC: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of APAC: Asparaginase Market, by End-User, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Servier Pharmaceuticals LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Biovendor, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Enzymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Taj Pharmaceuticals Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 medac GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Jazz Pharmaceuticals, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Changzhou Qianhong Biopharma Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 United Biotech (P) Limited
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)
Table 2. China Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. India Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 14. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 15. Australia Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 22. South Korea Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of APAC Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of APAC Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of APAC Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of APAC Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)
Table 27. Recent Inorganic Growth Strategies
Table 28. Recent Organic Growth Strategies
Table 29. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Asparaginase Market Segmentation
Figure 2. APAC Asparaginase Market Segmentation, by Country
Figure 3. APAC Asparaginase Market Overview
Figure 4. APAC Asparaginase Market, By Type
Figure 5. APAC Asparaginase Market, By Country
Figure 7. APAC: PEST Analysis
Figure 8. Experts Opinion
Figure 9. APAC Asparaginase Market Impact Analysis of Drivers and Restraints
Figure 10. APAC Asparaginase Market – Revenue Forecasts and Analysis
Figure 11. By Type: APAC Market Analysis and Forecast 2021 and 2028 (%)
Figure 12. APAC Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Pegylated Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. By Application: APAC Market Analysis and Forecast 2021 and 2028 (%)
Figure 17. APAC Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Food Processing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. By End-Use: APAC Market Analysis and Forecast 2021 and 2028 (%)
Figure 24. APAC Healthcare Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC: Asparaginase Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. APAC: Asparaginase Market, by Country, 2021 & 2028 (%)
Figure 28. China: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Japan: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. India: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Australia: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. South Korea: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of APAC: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)
- Biovendor, LLC
- Changzhou Qianhong Biopharma Co Ltd
- Creative Enzymes
- Jazz Pharmaceuticals, Inc.
- medac GMBH
- Servier Pharmaceuticals LLC
- Taj Pharmaceuticals Limited
- United Biotech (P) Limited
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC asparaginase market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution